Metformin, a common type 2 diabetes medication, is being investigated for its potential anti-cancer effects. Research ...

Jelly Roll is opening up about what it took to lose nearly 300 lbs. In an interview with Men’s Health published in January ...

New research now suggests that stopping diabetes drug metformin early may up the risk of developing thinking and memory problems as patients age. File Photo by Brian Kersey/UPI Millions of people with ...

Starting metformin is associated with a lower risk of developing osteoarthritis over 11 years of follow-up in a study ...

Metformin is an old drug. In its earliest form, it was an extract from lilacs and was purportedly used in the 1700s to treat what the French called “sweet urine disease,” which we now know as diabetes ...

Ozempic, or semaglutide, is a new obesity drug, delivered in the form of a hormone injection. Metformin is a pill that was first developed for type 2 diabetes. Both drugs can help people lose weight, ...

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...

Metformin, a medication commonly used to treat type 2 diabetes, helps the body regulate sugar in the bloodstream. Part of the class of drugs known as biguanides, metformin reduces the amount of sugar ...

WASHINGTON — Nostrum Laboratories is voluntarily recalling one lot of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according to a notice by the U.S.

A popular diabetes drug could be linked to major birth defects, according to researchers. In a study from Stanford University, the University of Southern Denmark and Copenhagen University, published ...

The widely used diabetes drug metformin changes blood metal levels in humans. The Kobe University study is an important step in understanding the drug's many actions and designing better ones in the ...

A safe, generic diabetes pill can help people avoid long COVID, a new clinical trial shows. Metformin cut the risk of long COVID by about 40% for patients who received a two-week course of the drug ...